Searched for
MRNA BIOTECH
GSK set to get $500 million from settlement of mRNA lawsuitCureVac NV has settled its US patent dispute with Pfizer and BioNTech SE regarding mRNA vaccines, resulting in GSK receiving up to $500 mil...- We can be VAXit Bharat: Public sector alone can’t make India biotech-ready; firms, startups must jump inWhile India grapples with rising Covid cases and prepares for potential biological threats, the government's neglect of its scientists' suc...
- Cipla makes additional investment in German mRNA biotechEthris' has four potential drugs under development pipeline, of which one is for treating uncontrolled asthma and three other for primary c...
- Emcure and its subsidiary Gennova settle legal dispute with HDT Bio over mRNA technologyEmcure Pharmaceuticals and its subsidiary Gennova have resolved all legal disputes with US-based HDT Bio Corp. The parties have entered int...
- Gennova eyes nod for omicron-specific vaxAs Covid-19 cases saw an uptick in other countries, the government in November approved Bharat Biotech's intranasal vaccine iNCOVACC for he...
- Indian vaccines should be used as boosters without any delay: ExpertsThis comes even as the government's advisory group on Covid-19 is awaiting data from the National Institute of Virology (NIV), Pune before ...
- Chinese firm buys Canada mRNA Covid vaccine tech in $500 million dealWhile almost 1 billion people have been fully vaccinated in China, the country is still lacking an mRNA shot, with most of the population i...
- BioNTech shot produces 10x more antibodies than Sinovac: StudyThe research, published in The Lancet, found that antibody levels among Hong Kong health workers who have been fully vaccinated with BioNTe...
- BioNTech to build mRNA manufacturing site in SingaporeThe biotech company said the Singapore production facility will have an estimated annual capacity of several hundred million doses of mRNA-...
- Vaccine tech transfer hard, next six months key in Covid fight, says leading vaccine makersOn Friday, senior executives from companies such as Moderna, GSK and Bharat Biotech addressed various issues on Covid vaccines, including e...
- Countries seek more Moderna, Pfizer/BioNTech shots as concerns mount over rival vaccinesCountries in Europe and Asia, as well as South Africa, are limiting or halting use of AstraZeneca's shot over safety concerns. Rollout of J...
- HGCO19 vaccine candidate: Gennova starts enrolment for Phase 1/2 human clinical trialsThe DBT said it has approved additional funding towards clinical studies of India's first of its kind' mRNA-based COVID-19 vaccine, HGCO19,...
- EU seeks new contract with Pfizer/BioNTech for up to 1.8 bln vaccines from 2022: EU sourceThe EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer...
- US buys additional 100 million doses of Moderna vaccineThe agreement brings the total number of Moderna doses bought by the US to 200 million, enough to immunize 100 million people with the two-...
- Gennova Biopharmaceuticals granted conditional permission for human clinical trial of its COVID-19 vaccineThe recommendations of the Subject Expert Committee (SEC) on COVID-19, which deliberated upon the proposal submitted by the firm for grant ...
- Moderna's mRNA coronavirus vaccineIt will seek emergency use authorization from the U.S. Food and Drug Administration and conditional approval from the European Union on Mon...
- Moderna vaccine results 'stunningly impressive,' Fauci tells AFP"The idea that we have a 94.5 percent effective vaccine is stunningly impressive. It is really a spectacular result that I don't think anyb...
- Gennova Biopharma to start mRNA vaccine trials by the year's end; results likely in March '21The trial results are likely to come in by March 2021, Sanjay Singh, CEO of Pune-based Gennova, told ET. There is a possibility that India ...
- GSK collaborates with Germany's CureVac, set to take 10% stake for $163 millionBritain's GSK said on Monday it would invest 130 million pounds ($163 million) in German biotech firm CureVac for a 10% stake to work toget...
- Wipro founder Azim Premji is an early investor in US firm ModernaWipro founder Azim Premji is an investor in Moderna, the firm that has emerged a frontrunner for Covid vaccine.
Load More
